Biocare Medical, Bethyl Laboratories partner for antibody development

By The Science Advisory Board staff writers

June 29, 2020 -- Biocare Medical has formed a strategic partnership with Bethyl Laboratories to develop targeted antibodies for cancer research.

Through the partnership, Bethyl's research antibodies will be accelerated into the clinical market. Biocare will provide Bethyl with premier access to its Valent automated immunohistochemistry platform to develop products for early-stage research, companion diagnostics development, and diagnostic workflow optimization.

Bethyl will also work with Biocare to develop novel solutions in automated immunohistochemistry workflows to expand platform options available to pharmaceutical and biotechnology research institutions.


Copyright © 2020 scienceboard.net
 


Email Address:

First Name:

Last Name:

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.